GlassScriptPhysician profile
Rosemary Buckle
NPI 1083690846
$200,561.08
in general payments reported to CMS, 2019-2025
16 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143K · 2020: $40K · 2021: $4,055 · 2022: $3,490 · 2023: $7,712 · 2024: $1,321 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,925 · Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,925.00 |
| Food and Beverage | $384.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $199,737.34 | 2019-2025 | Axsos, T2 Alpha, Variax |
| Nevro Corp. | $177.01 | 2020-2021 | |
| Illuminoss Medical, INC. | $166.66 | 2020-2021 | |
| Horizon Therapeutics Plc | $108.54 | 2019-2020 | |
| Bioventus LLC | $87.39 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $60.03 | 2022-2024 | Aquamantys(Tm) |
| Smith+Nephew, INC. | $46.13 | 2019-2021 | |
| Zyla Life Sciences, INC. | $30.16 | 2019 | |
| Amgen INC. | $29.29 | 2025 | Evenity |
| Medinc of Texas | $27.06 | 2022 | |
| Orthalign INC | $23.42 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.11 | 2023 | Seglentis |
| Innovation Technologies INC | $13.91 | 2022 | |
| Abbott Laboratories | $13.45 | 2021 | |
| Dynasplint Systems INC. | $12.09 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $9.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosemary Buckle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.